Cure Research for Age-related macular degeneration
Treatments for Age-related macular degeneration
Treatments to consider for Age-related macular degeneration may include:
Medical Research Breakthroughs and Age-related macular degeneration
Lower Risk of Macular Degeneration In Postmenopausal women on Hormones: According to a recent study conducted
researchers found that there is an association between women who take
postmenopausal hormones and the risk of developing age-related macular degeneration.
It was noted that especially for women who had taken oral contraceptives;
postmenopausal hormones reduced the risk of progression to advanced stages of
the eye disease. Among older adults, age-related macular degeneration (AMD) is the chief cause
of blindness and loss of vision. Genetics plays a key role in susceptibility to
AMD but environmental factors, such as smoking, are also important. There was
evidence of higher rates of AMD in women than in men and also the discovery of
links between AMD and cardiovascular disease suggested the involvement of estrogens
in development of the disease.
It was found that current postmenopausal hormone users had a 48 percent
lower risk of neovascular AMD compared with those who had never used
postmenopausal hormones, the risk did not decline with longer durations of use.
The risk was lowest for postmenopausal hormone users who had used oral
contraceptives in the past.
However, oral contraceptive use was not linked to early AMD risk, but current
postmenopausal hormone users were 34% more likely to develop early stage AMD
than non-users, hence a higher risk of early AMD was seen among postmenopausal hormone.
In addition, researchers found a 26% lower risk of early AMD among women who
had given birth. Altogether, these findings suggest a role for estrogen in the pathogenesis of
AMD that requires further research in specific early and late signs of disease.
Cure Research discussion for Age-related macular degeneration:
Age-Related Macular Degeneration Status of Research: NEI (Excerpt)
Researchers are exploring and developing treatment strategies, such
as gene replacement, anti-angiogenesis factors, and pharmacological
agents, to correct or delay the progression of the vision loss
associated with AMD. (Source: excerpt from Age-Related Macular Degeneration Status of Research: NEI)
Age-Related Macular Degeneration Status of Research: NEI (Excerpt)
Groups of NEI-supported scientists have successfully transplanted
healthy retinal pigment and photoreceptor cells into diseased retinas of
laboratory animals. In addition to the above, the NEI recognizes that
age-related macular degeneration is a leading cause of severe visual
impairment in the United States, and the Institute is supporting research
on low vision aids, devices, and other strategies for those who suffer
from visual impairment. The NEI is also developing a new, low vision
public education program as part of its National Eye Health Education
Program. This new program will inform people about available low vision
aids and services that can help them with their daily activities, such as
reading, sewing, and driving, to improve their quality of life. (Source: excerpt from Age-Related Macular Degeneration Status of Research: NEI)
Age-Related Macular Degeneration Status of Research: NEI (Excerpt)
The Age-Related Eye Disease Study also includes clinical trials that
will help determine the effects of certain vitamins and minerals in
preventing or slowing the progress of AMD. In particular, researchers
are closely examining whether vitamins C and E, beta-carotene, and/or
zinc can provide the macula with greater protection, thereby preventing
or slowing progression of the disease. If dietary supplements prove
effective, it would have a huge impact on AMD treatment and reduce the
need for low vision services and devices for older Americans. It should
be noted that on occasion, seemingly benign nutrients such as vitamins
and minerals can be harmful when taken inappropriately, especially
vitamins that accumulate in body fat. When the Age-Related Eye Disease
Study is completed within the next five years, we will know whether any
of these vitamin and mineral combinations are both effective and safe
therapy for macular degeneration.
(Source: excerpt from Age-Related Macular Degeneration Status of Research: NEI)
Age-Related Macular Degeneration Status of Research: NEI (Excerpt)
Replacing diseased retinal cells with healthy ones is a promising
area of research. NEI scientists are determining whether retinal cell
transplants are useful to treat the retinal degeneration caused by AMD.
Groups of NEI-supported scientists have successfully transplanted
healthy retinal pigment and photoreceptor cells into diseased retinas of
laboratory animals.
(Source: excerpt from Age-Related Macular Degeneration Status of Research: NEI)
Facts About Age-Related Macular Degeneration: NEI (Excerpt)
Findings from the NEI-sponsored Age-Related Eye Disease Study
(AREDS) showed that high levels of antioxidants and zinc
significantly reduces the risk of advanced age- related macular
degeneration (AMD) by about 25 percent. (Source: excerpt from Facts About Age-Related Macular Degeneration: NEI)
Medical research for Age-related macular degeneration: medical news summaries:
The following medical news items
are relevant to medical research for Age-related macular degeneration:
Age-related macular degeneration Treatment: Book Excerpts
Clinical Trials for Age-related macular degeneration
Some of the clinical trials for Age-related macular degeneration include:
Evidence Based Medicine Research for Age-related macular degeneration
Medical research papers related to Age-related macular degeneration include:
Click here to find more evidence-based articles on the TRIP Database
When you reach a certain age, it's usually clear that your vision isn't as sharp as it used to be. Learn how surgery for the cloudy lens of a...
Some treatment options are not available for patients with chronic myeloid leukemia when they are over 65 years old. But most can still look forward...
We all know that it is important to keep your body active and healthy to live a long life. But the old adage "use it or lose it" is also true....
At 72-years of age, Ginette Bedard is the world's fastest marathon runner for her age group. What's her secret?
See full list of 5 related videos
» Next page: Statistics about Age-related macular degeneration
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
